65--Manufacture/Distributor Br-Philadelp

Key Dates
Due Date

-

Posted Date

-

Agency & Value
Agency

DLA TROOP SUPPORT

Contract Value

Not provided

Codes & Classification
Solicitation Number

SPE2D221R01080001

NAICS

325412 - Pharmaceutical Preparation Manufacturing

Classification Code

65

Additional Details
Set Aside

None

Place of Performance

-

SourceSAM
This award notice pertains to a procurement activity conducted by DLA Troop Support, a federal office responsible for providing logistical support to military and other government entities. The notice, titled "65--Manufacture/Distributor Br-Philadelp," indicates the completion of a contract under procurement identifier SPE2D221R01080001. The primary focus of this procurement falls under NAICS Code 325412, which covers Pharmaceutical Preparation Manufacturing, as defined in the 2022 NAICS version. This classification suggests that the contract involves the manufacturing or distribution of pharmaceutical products, likely intended to support the health and medical readiness of the agency’s stakeholders. The Product Service Code associated with this notice is 65, further confirming the medical and pharmaceutical nature of the deliverables. While specific product details, quantities, or technical requirements are not provided in the notice, contractors can infer that the scope centers on the supply of pharmaceutical preparations, either through direct manufacturing or authorized distribution channels. DLA Troop Support, as the contracting entity, operates from Philadelphia and serves as a critical procurement arm for defense-related supplies. The notice lists Jason C. Wray as the primary contact, available at 215-737-0614 and via email at [email protected], for any inquiries related to this procurement. The opportunity was originally posted on January 26, 2022, and is now marked as inactive, indicating that the award process has concluded. This procurement was posted on SAM.gov, the official U.S. government system for contract opportunities, under Opportunity ID 01723f3adc5c40349c34a47b32efe61b. No attachments or additional documents are referenced in the notice, and there are no indications of set-aside requirements or special considerations such as small business preferences. For contractors evaluating similar opportunities, the key elements to consider are the requirement for pharmaceutical manufacturing or distribution capabilities, compliance with federal standards, and the ability to support the logistical needs of DLA Troop Support. The contract’s core objectives are likely to remain focused on the reliable supply of pharmaceutical products to support federal operations, with expectations for quality, timeliness, and regulatory adherence throughout the contract lifecycle.